Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001104659-16-151611

10% owner acquired 744,380 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Hadley Harbor Master Investors (Cayman) L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-10-24 Conversion : show line 1 in the form +744,380 744,380 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2016-10-24 Conversion : show line 2 in the form Series B Convertible Preferred Shares −744,380 744,380 0 D
Loading xslF345X03/a4.xml…